nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—adrenal gland cancer	0.739	0.778	CbGaD
Amsacrine—ABCB1—adrenal gland cancer	0.21	0.221	CbGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—PRKACA—adrenal gland cancer	0.0031	0.0784	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—DAXX—adrenal gland cancer	0.00257	0.065	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—MED12—adrenal gland cancer	0.002	0.0506	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—SH3KBP1—adrenal gland cancer	0.00195	0.0494	CbGpPWpGaD
Amsacrine—NCOA3—adrenal cortex—adrenal gland cancer	0.0017	0.151	CbGeAlD
Amsacrine—NCOA3—PPARA activates gene expression—MED12—adrenal gland cancer	0.0015	0.038	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00148	0.0373	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00147	0.0372	CbGpPWpGaD
Amsacrine—NCOA3—gonad—adrenal gland cancer	0.00141	0.125	CbGeAlD
Amsacrine—NCOA3—cardiac atrium—adrenal gland cancer	0.00141	0.125	CbGeAlD
Amsacrine—NCOA3—pituitary gland—adrenal gland cancer	0.00138	0.122	CbGeAlD
Amsacrine—KCNH2—Potassium Channels—KCNJ5—adrenal gland cancer	0.00132	0.0333	CbGpPWpGaD
Amsacrine—CYP2D6—urine—adrenal gland cancer	0.00129	0.114	CbGeAlD
Amsacrine—NCOA3—adrenal gland—adrenal gland cancer	0.00123	0.109	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—SPRY2—adrenal gland cancer	0.00115	0.0291	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.0011	0.0279	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00107	0.027	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00101	0.0256	CbGpPWpGaD
Amsacrine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000967	0.0244	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NR5A1—adrenal gland cancer	0.000753	0.019	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000723	0.0183	CbGpPWpGaD
Amsacrine—TOP2A—adrenal gland—adrenal gland cancer	0.000722	0.0639	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.000689	0.0174	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.000683	0.0173	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000612	0.0155	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—KCNJ5—adrenal gland cancer	0.000576	0.0146	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000569	0.0144	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—CTNNB1—adrenal gland cancer	0.000516	0.013	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.000506	0.0128	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000504	0.0127	CbGpPWpGaD
Amsacrine—KCNH2—cardiac atrium—adrenal gland cancer	0.000463	0.041	CbGeAlD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000459	0.0116	CbGpPWpGaD
Amsacrine—KCNH2—pituitary gland—adrenal gland cancer	0.000453	0.0401	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—MED12—adrenal gland cancer	0.000452	0.0114	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000451	0.0114	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.000442	0.0112	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000434	0.011	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—EGFR—adrenal gland cancer	0.000409	0.0103	CbGpPWpGaD
Amsacrine—KCNH2—adrenal gland—adrenal gland cancer	0.000404	0.0358	CbGeAlD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000404	0.0102	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.000401	0.0101	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SDHB—adrenal gland cancer	0.000374	0.00946	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000351	0.00888	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—adrenal gland cancer	0.000343	0.00868	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000332	0.00838	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000307	0.00777	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000303	0.00765	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000295	0.00745	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CDC42—adrenal gland cancer	0.00028	0.00707	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000263	0.00664	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000248	0.00628	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000246	0.00622	CbGpPWpGaD
Amsacrine—ABCB1—adrenal cortex—adrenal gland cancer	0.000246	0.0218	CbGeAlD
Amsacrine—NCOA3—Metabolism—SDHD—adrenal gland cancer	0.000241	0.0061	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—RRM1—adrenal gland cancer	0.000241	0.0061	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—PRKACA—adrenal gland cancer	0.000221	0.00558	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000221	0.00558	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000216	0.00547	CbGpPWpGaD
Amsacrine—ABCB1—gonad—adrenal gland cancer	0.000204	0.018	CbGeAlD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000202	0.00509	CbGpPWpGaD
Amsacrine—ABCB1—pituitary gland—adrenal gland cancer	0.000199	0.0176	CbGeAlD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.00019	0.00481	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000187	0.00473	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000183	0.00463	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MED12—adrenal gland cancer	0.00018	0.00455	CbGpPWpGaD
Amsacrine—ABCB1—adrenal gland—adrenal gland cancer	0.000177	0.0157	CbGeAlD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000162	0.0041	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000161	0.00407	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00015	0.0038	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00015	0.00379	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000137	0.00346	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000135	0.0034	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PRKACA—adrenal gland cancer	0.000134	0.00339	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000132	0.00334	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PRKACA—adrenal gland cancer	0.000131	0.00332	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—adrenal gland cancer	0.000129	0.00325	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000128	0.00324	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000121	0.00305	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—adrenal gland cancer	0.000119	0.00301	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000116	0.00293	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000107	0.00271	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GNAS—adrenal gland cancer	0.000106	0.00269	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCB1—adrenal gland cancer	0.000104	0.00264	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—adrenal gland cancer	0.000102	0.00257	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	9.55e-05	0.00241	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—adrenal gland cancer	9.11e-05	0.0023	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	8.02e-05	0.00203	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	7.93e-05	0.002	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	7.7e-05	0.00195	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—POMC—adrenal gland cancer	7.16e-05	0.00181	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RB1—adrenal gland cancer	7.09e-05	0.00179	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	6.97e-05	0.00176	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	6.24e-05	0.00158	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.03e-05	0.00152	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—adrenal gland cancer	5.71e-05	0.00144	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	5.7e-05	0.00144	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDHB—adrenal gland cancer	5.41e-05	0.00137	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	5.09e-05	0.00129	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.44e-05	0.00112	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.05e-05	0.00102	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.97e-05	0.001	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDHD—adrenal gland cancer	3.48e-05	0.00088	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RRM1—adrenal gland cancer	3.48e-05	0.00088	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—adrenal gland cancer	3.47e-05	0.000877	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	3.28e-05	0.00083	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	3.28e-05	0.00083	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.28e-05	0.000829	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.14e-05	0.000795	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.64e-05	0.000667	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MED12—adrenal gland cancer	2.6e-05	0.000656	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.45e-05	0.000619	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.89e-05	0.000479	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.79e-05	0.000451	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.54e-05	0.000388	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.45e-05	0.000366	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.42e-05	0.000359	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.03e-05	0.000261	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—POMC—adrenal gland cancer	9.74e-06	0.000246	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	8.25e-06	0.000208	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	7.77e-06	0.000196	CbGpPWpGaD
